This study shows that the clinical course of COVID-19 transplant patients is similar to that of the general population.
In particular, it is found that the incidence rate of infection is similar between transplanted patients (21 per 5000 patients) and the general population (284 per 100,000 inhabitants as of April 6, 2020).
The clinical presentation and mortality are similar to those of the general population, but the small number of patients included in the study and the lower average age than the general population (56 years vs 70 years) must be taken into account, as this may partly explain the good results of the patients.
The sample tested had lower inflammatory parameter values than the inpatient population (PCR 33mg/l vs 48 mg/l and D-dimer 0.39 μg/ml vs 0-96 μg/ml).
These results should be evaluated in larger cohort studies with appropriate controls.
IF : LOW
1) Multi-centre observational cohort study
2) Small sample (n=21)
3) Short follow-up (average= 33 days)
4) Possible selection bias: only symptomatic patients were screened by RT-PCR
Multicentric observational cohort study based on the Swiss Transplant Cohort Study (STCS), a cohort study including more than 90% of the patients who have undergone organ transplantation in Switzerland since 2008.
All STCS patients with a positive RT-PCR test for SARS-CoV-2 between March 9, 2020 and April 6, 2020 were included in the study.
A total of 21 transplant patients were included (10 kidneys, 5 livers, 1 lung, 1 heart and 3 transplants combined).
bibliovid.org and its content are bibliovid property.